Archive for August, 2009
Cytogen’s AxCell Biosciences and Molecular Staging to Investigate Biochips to Accelerate Mapping of Human Proteome
August 27th, 2009
| 
Author: 
Posted in 
Cytogen Corporation to Acquire Novel Diagnostic Technology from Molecular Staging, Inc. to Develop Improved Prostate Cancer Tests
Lift Off For Rival DNA Technology
The Anglo-Swedish company Amersham Pharmacia Biotech has signed an exclusive deal to develop a rival technology to PCR (Polymerase Chain Reaction), which has become one of the fundamental tools of molecular biology.
PCR was invented by Californian scientist Kary Mullis, and won him a share of the Nobel Prize for Chemistry in 1993.
Read the rest of this entry »
Multiplexed Protein Profiling on Protein Chips Using Rolling Circle Amplification
NEW HAVEN, April 18, 2002/– Molecular Staging Inc. (MSI) today announced the publication of a landmark paper in this month’s issue of Nature Biotechnology that describes a new approach to analyzing multiple proteins simultaneously on a glass chip microarray.
The paper, entitled “Multiplexed Protein Profiling on Microarrays using Rolling Circle Amplification (RCAT),” describes a chip based proteomics discovery platform that employs RCAT to amplify signals from proteins in a highly multiplexed format.
Read the rest of this entry »
New Technology Increases the Availability of
NEW
HAVEN, April 16, 2002/– Molecular Staging Inc.
(MSI) today announced the publication of a paper in
today’s issue of Proceedings of the National Academy of
Sciences of the United States of America (PNAS) that
describes a method for generating millions of DNA copies
from just a few cells.
Molecular Staging Inc. Awarded Three Additional Patents for Rolling Circle Amplification Technology
NEW HAVEN, April 4, 2002/– Molecular Staging Inc. (MSI) today announced that it has been awarded three additional patents for Rolling Circle Amplification Technology (RCATTM). MSI now has a total of fourteen issued patents in the U.S., Europe and Australia covering this technology and its applications.
Read the rest of this entry »
Study Demonstrates Increased Sensitivity Of Rolling Circle Amplification TechnologyTM In Detecting Nucleic Acids On Microarrays
NEW HAVEN, CT, December 11, 2001 - Molecular Staging Inc. (“MSI”) today announced publication of a paper in the November issue of Nucleic Acids Research that describes the application of the Company’s proprietary Rolling Circle Amplification Technology (RCATTM) to detect nucleic acids on microarrays.
Read the rest of this entry »
Circle AmplificationTM in Detecting Allergen-specific IgE on Microarrays Published
NEW HAVEN, CT., October 30, 2001/– Molecular Staging Inc. (MSI) today announced a published abstract in the October 2001 issue of Clinical Chemistry. The abstract described the application its of MSI’s Rolling Circle Amplification TechnologyTM (RCATTM) for the detection of allergen-specific IgE, the antibody in patient serum used to predict an allergic response in individuals with concordant clinical history.
Read the rest of this entry »
Molecular Staging Inc. Receives SBIR Grant From The National Cancer Institute
NEW HAVEN, October 8, 2001 /– Molecular Staging Inc. (MSI) announced today that it received a Small Business Innovative Research (SBIR) grant to develop a method of detecting rare Human Papillomavirus (HPV) transformed cells using Rolling Circle Amplification Technology (RCATTM).
Read the rest of this entry »
Molecular Staging Inc. Awarded Two Additional Patents For Rolling Circle Amplification Technology
NEW
HAVEN, September 27, 2001/– Molecular Staging Inc.
(MSI) announced today that it has been awarded two
additional patents for Rolling Circle Amplification
Technology (RCATTM).
This further expands the
intellectual property estate surrounding MSI’s Rolling
Circle Amplification Technology to a total of 11 issued
patents, including eight U.S. patents and three
international patents.
Rolling Circle
Amplification Technology detects and measures proteins as
well as nucleic acids with unprecedented sensitivity and
expanded multiplexing capabilities.